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LETTER
Better data for country-level TB resource allocation are urgently
required
Dear Editor,
Recently, there has been a global effort to
standardise cost reporting and collect evidence for
programmatic costs (see A to B in Figure 1A),
including the Global Health Cost Consortium
(GHCC) Unit Cost Study Repository,1 the VALUE
TB project2 and the iDSI (International Decision
Support Initiative) reference case.3 However, these do
not link the costs of activities to the health benefits
provided. There are ongoing efforts to collect cost-
effectiveness evidence for epidemiological impact, but
estimates are only available for a limited number of
interventions applied to very specific populations
(e.g., HIV-positive, prison inmates etc).4 Further-
more, the COVID-19 pandemic has increased the
pressure on health resources.5 As such, health impact
is frequently not linked to a quantifiable amount of
resources/activities, so the crucial link between
resource needs and impact remains unknown. With-
out evidence linking resource need to both impact and
cost, country-level decision-makers are largely left to
rely on expert opinion to help make resource
allocation decisions.6,7
To efficiently allocate limited resources, national
tuberculosis programme (NTP) staff and technical
assistance (TA) teams need to know the likely cost
and health impact of available intervention packages.
The packages can be quantified by the resources they
require to achieve a quantified health impact. This
can be categorised into: 1) what resource needs are
required for an intervention (e.g., the amount of nurse
time and the number of diagnostics); 2) the total cost
of these resources (e.g., the unit cost multiplied by the
resource amount); and 3) the likely increase in health
impact (e.g., an increase in treatment success).
An important example is active case finding
(ACF),8 as spending on ACF interventions, such as
the $125m allocated to ‘finding the missing millions’
in the Stop TB/WHO Global plan,9,10 and the
epidemiological impact have been systematically
reviewed for the WHO guidelines for ACF interven-
tions.11 However, the resources required to achieve
these impacts (see A to C in Figure 1A) have not been
collated, and therefore the information decision-
makers need for resource allocation remains severely
limited.12–14
To help fill these gaps, we investigated the resource
needs data reporting in evaluations of ACF. From
published ACF evaluations,15 we recorded informa-
tion on 1) the diagnostic algorithm used; 2) the
number of tests performed per diagnostic step in the
algorithm; 3) human resource requirements; 4)
training provided; and 5) auxiliary resource require-
ments. These were categorised into those with a
‘Basic’ (1, 2), ‘Intermediate’ (1–3), ‘Comprehensive’
(1–5), or no reporting of resource needs. Evaluations
were identified from Kranzer et al.’s systematic
review15 and the WHO ACF guidelines (which were
co-developed with the review).11 Full details of the
search strategy and inclusion and exclusion criterion
are outlined in the review, but in summary the review
set out four questions on the impact of screening on
TB, which formed the basis of the inclusion criterion.
Studies were excluded if TB infection was not defined
as active and if they were in a language other than
English, Spanish, French, Russian or Japanese. The
evaluations identified were then searched for using
electronic searches and in correspondence with the
original works authors. Five original papers could not
be located. We identified 65 evaluations to be re-
reviewed for data on resource need.
Most evaluations (75%, 49/65) included a descrip-
tion of the diagnostic sequence, but only 38% (25/65)
included data on diagnosis resource requirement;
18% (12/65) included data on human resources, 14%
(9/65) on training and 18% (12/65) on auxiliary
activities; 22% (14/65) of studies did not report any
resource needs information. Thus, the evaluations
were classified as Basic (25/65, 38%), Intermediate
(7/65, 11%) and Comprehensive (2/65, 3%) in
reporting resource needs data (Figure 1B). A detailed
database of these data are available at http://tb-mac.
org/tb-mac-resource/activity-to-impact-data-and-
checklist/. Our results suggest that there is evidence
available in the existing ACF evaluation literature
that could be used to better support country-level
resource allocation decision-making.
However, while there are data available to evidence
ACF intervention resource needs, our results also
show that there is seldom more than a basic level.
Estimates of resource needs for resource allocation
based on these limited data are likely to be an
underestimate of the actual resource needs, as the
data fail to include information on the essential
human resources, training and additional auxiliary
resources and support required. These resource needs
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may also incur a significant opportunity cost to the
health system, as interventions are not run in isolation
of staff and support. In addition, for intervention
effects to be validated and replicated across different
settings, it is important that these resource needs are
recorded in addition to the context, health impact and
costs. To this end, we proposed resource-needs
reporting (see http://tb-mac.org/tb-mac-resource/
activity-to-impact-data-and-checklist/ ) and would
welcome your input (please contact the correspond-
ing author of this article).
Many of these evaluations were originally carried
out to investigate health outcomes, not necessarily to
collect data on resource needs. Therefore, our aim
was not to comment on the quality of any specific
evaluation, but rather to assess the availability of
resource needs data that could also be linked directly
to a measured health impact. However, we hope our
work does provide a useful case study on the likely
resource data availability across a wide variety of
evaluation types. ACF interventions are subject to
large variability in resource needs, so the groupings
we used (Basic, Intermediate or Comprehensive) may
not be appropriate for all interventions.10
The data in our database provide an additional
useful source for decision-makers and their TA teams
to identify ACF evaluations containing resource
needs data, from which cost-effectiveness and budget
impact estimates can be made, without relying on
expert opinion.6,7 Our results highlight the need for
additional data collection and collation, particularly
those quantifying resource needs and epidemiological
impact, to ensure that decision-makers have adequate
access to evidence to inform decisions they face when
attempting to allocate limited resources across a
range of interventions. This would benefit from the
development of a reference case similar to those for
collecting cost data.3
In summary, existing evaluations do contain useful
information, which could be used for resource
allocation decision-making at a country level, but
these data need to be collated and are likely to
underestimate resource needs. We advocate for more
extensive reporting of resource needs in future TB
intervention evaluations, and further work to make
resource needs data available in other areas of TB
care and prevention. This would support better
decision-making and save lives.
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